Bio


Dr. Marie Jetté is a clinician-scientist and Clinical Associate Professor in the Department of Otolaryngology–Head and Neck Surgery at Stanford University School of Medicine. She is a speech-language pathologist specializing in the behavioral assessment and treatment of voice and upper airway disorders, with particular expertise in refractory chronic cough, and gender-affirming voice care. Dr. Jetté joined the Stanford faculty in September 2026 after serving on the faculty at the University of Colorado Anschutz.

Dr. Jetté graduated from the University of British Columbia in Vancouver, Canada, with a bachelor's degree in linguistics and speech science in 2003. She earned her master's degree in speech-language pathology from the MGH Institute of Health Professions in Boston, Massachusetts in 2006. Following her clinical graduate training, she completed a clinical fellowship specializing in voice disorders at the Massachusetts General Hospital Center for Laryngeal Surgery and Voice Rehabilitation in 2007. She subsequently earned her PhD in communication science and disorders from the University of Wisconsin-Madison in 2015.

Dr. Jetté's clinical practice focuses on the evaluation and behavioral treatment of voice and upper airway disorders. She works collaboratively with laryngologists, pulmonologists, and other healthcare professionals to provide comprehensive, multidisciplinary care for patients with complex laryngeal conditions. Her clinical approach emphasizes individualized, evidence-based behavioral interventions to improve vocal function, reduce symptom burden, and enhance patients' quality of life.

As a clinician-scientist, Dr. Jetté conducts clinical and translational research focused on understanding the physiological, sensory, and behavioral mechanisms underlying voice and upper airway disorders. She is a principal investigator of a National Institutes of Health (NIH)-funded, multisite clinical trial investigating the mechanisms of change associated with behavioral cough suppression treatment for refractory chronic cough. Her research integrates behavioral interventions, objective physiological measures, and functional magnetic resonance imaging (fMRI) to investigate the neural and behavioral mechanisms underlying treatment response. Her overarching research goal is to advance the understanding of laryngeal function and develop more effective, individualized treatments for patients with voice and upper airway disorders.

Dr. Jetté is actively involved in scientific publishing, professional education, and service to the fields of speech-language pathology and laryngology. She has served on numerous committees for the American Speech-Language-Hearing Association (ASHA) and as a board member of the Colorado Speech-Language-Hearing Association. She has served on the editorial boards of the Journal of Speech, Language, and Hearing Research, the Journal of Voice, and PLOS ONE. She has served as a co-chair of the Fall Voice conference three times, including as Overall Program Chair in 2026. Dr. Jetté has also reviewed career development awards for the National Heart, Lung, and Blood Institute (NHLBI), served as a site visitor for the Council on Academic Accreditation in Audiology and Speech-Language Pathology (CAA), and organized large-scale educational workshops to train speech-language pathologists in gender-affirming voice care. She is also committed to mentoring the next generation of clinician-scientists and academic leaders, actively mentoring doctoral students, postdoctoral fellows, and early-career faculty through ASHA-sponsored mentoring programs.

Academic Appointments


  • Clinical Associate Professor, Otolaryngology (Head and Neck Surgery)

Administrative Appointments


  • Clinical Associate Professor, Stanford University (2026 - Present)

All Publications


  • Towards a consensus on the definition and nature of meta-therapy in voice therapy: Current state and future directions. International journal of speech-language pathology Helou, L. B., Martineau, S. M., Gartner Schmidt, J. L., Almand, K. B., Battipaglia, J., Becker, D. R., Blanca, A., Fritz, R., Hammerle, B. K., Hapner, E., Jetté, M. E., Krusemark, C., Litts, J. K., McDowell, S. K., Merrick, G., Murphy Estes, C., Nicastro, G., Norotsky, R. L., Petty, B. E., Philippone, M., Rosenberg, M., Samlan, R. A., Schneider, S., Seymour, M., Tripp, R. M. 2026: 1-17

    Abstract

    Meta-therapy is the nuanced relational dialogue employed by clinicians to facilitate effective and efficient behavioural change. Introduced within the context of voice therapy and recently applied in other domains of speech-language pathology, meta-therapy continues to evolve conceptually. This article presents a preliminary effort towards consensus-building about meta-therapy.A structured expert consensus development process was conducted with voice-specialised speech-language pathologists using elements of a modified Nominal Group Technique and developmental pre-Delphi construct refinement. Sixteen clinicians and three facilitators participated in a three-hour online meeting incorporating presentation, guided discussion, case-vignette analysis, and anonymous polling to refine conceptual boundaries of meta-therapy. Four additional co-authors reviewed the meeting recording. These 23 and two additional speech-language pathologists with prior exposure and expertise in meta-therapy contributed to iterative manuscript drafting and revision.Meta-therapy may distinguish experienced from novice voice clinicians. We refined the definition and disambiguated meta-therapy from indirect and direct therapy, counselling, and education. We proposed the function and role of meta-therapy in the context of voice therapy, next steps, and future directions.This work represents the first attempt to seek consensus on how to define and operationalise meta-therapy as it pertains to voice therapy. Many concepts presented here should apply to other domains of behavioural therapy within the speech-language pathology field and in other rehabilitative fields. This work may guide future research in meta-therapy, including formal attempts to achieve consensus about the definition and nature of meta-therapy.

    View details for DOI 10.1080/17549507.2026.2724385

    View details for PubMedID 42911551

  • Validation Approaches for Cough Monitoring Tools: A Scoping Review. Lung Ramos Arriaza, L., Slovarp, L., Abell, B. D., Galvosas, M., Grandjean Lapierre, S., Jetté, M. E. 2026; 204 (1)

    Abstract

    To characterize validation approaches used in ambulatory cough monitoring systems and identify methodological variability that may limit clinical and research applications.Scoping review.A comprehensive search was performed in Embase (last updated May 8, 2026), and was limited to English-language, peer-reviewed human studies.This review followed PRISMA-ScR guidelines. Studies were included if they reported validation of cough monitoring systems in human participants or human-derived datasets. Two reviewers independently screened and selected studies, with discrepancies resolved by a senior author. Data were extracted using a standardized form and synthesized descriptively.Fifty studies met inclusion criteria. Most studies evaluated adult populations (72%) and were conducted in laboratory (29%) or home (25%) settings. Validation approaches were heterogeneous, with manual human annotation used as the reference standard in 66% of studies, neural network-based approaches in 12%, and alternative methods in 22%. Definitions of cough events and outcome metrics varied widely, including counts of cough events, epochs, and time-based measures. Technologies ranged from audio-based systems to wearable sensors and machine learning-enabled platforms. While many systems demonstrated high accuracy in controlled environments, performance in real-world settings was more variable, particularly in the presence of background noise and multiple speakers.Validation of cough monitoring systems remains highly heterogeneous, with no standardized framework for reference measures or outcome metrics. Manual annotation is the most commonly used reference standard, although annotation methods and cough event definitions vary across studies. Standardization of validation protocols, development of shared datasets, and incorporation of real-world testing are needed to support clinical translation of cough monitoring technologies.

    View details for DOI 10.1007/s00408-026-00907-w

    View details for PubMedID 42365132

  • Behavioural cough suppression therapy: a twisting journey to frontline therapy for refractory chronic cough ERJ OPEN RESEARCH Sundar, K. M., Jette, M. E. 2026; 12 (3)
  • Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Diagnostic Testing and Clinical Approach Based on the San Diego Consensus. Neurogastroenterology and motility O'Rourke, A., Sweis, R., Jette, M., Cates, D., Rameau, A., Roman, S., Xiao, Y., Zerbib, F., Yadlapati, R., Gyawali, C. P. 2026; 38 (5): e70351

    Abstract

    The San Diego Consensus for Laryngopharyngeal Symptoms (LPS) and Laryngopharyngeal Reflux Disease (LRPD) offers a modern interdisciplinary paradigm that focuses on symptoms and aligns evaluation with underlying mechanisms of disease.This review uses the San Diego Consensus as the framework to discuss who should be tested for reflux, timing and selection of diagnostic testing, and practical diagnostic algorithms in patients with LPS and LPRD. Patient reported outcome measures are useful to characterize LPS, quantify symptom burden and monitor response, but are not specific for a diagnosis of LPRD. Patients presenting with both LPS and typical esophageal symptoms have higher pretest probability of LPRD, and time limited empiric acid suppressive agents and alginates may be appropriate. In contrast, upfront objective testing is recommended in isolated LPS prior to long-term acid suppressive therapy. Laryngoscopy or stroboscopy can identify alternative etiologies of LPS. Esophagoscopy can demonstrate conclusive reflux evidence, but diagnostic yield is low. pH-impedance monitoring, especially with hypopharyngeal sensors, assesses reflux mechanisms when investigating LPS, and can provide numbers of reflux episodes irrespective of acidity as well as proximal extent of these episodes. High-resolution manometry does not provide a diagnosis of LPRD but serves to rule out motility disorders that mimic LPS. Prolonged wireless pH monitoring may be appropriate when typical esophageal reflux symptoms coexist. The evaluation of LPS requires a paradigm shift away from reflexive attribution to reflux and toward a structured diagnostic approach that systematically considers alternative etiologies of LPS.

    View details for DOI 10.1111/nmo.70351

    View details for PubMedID 42178700

    View details for PubMedCentralID PMC13601945

  • Behavioural cough suppression therapy: a twisting journey to frontline therapy for refractory chronic cough. ERJ open research Sundar, K. M., Jetté, M. E. 2026; 12 (3)

    Abstract

    Behavioural cough suppression therapy by speech pathologists for refractory chronic cough exhibits different trajectories of improvement that are independent of sex, age and duration of cough but affected by comorbid asthma and history of smoking https://bit.ly/4b0JPxi.

    View details for DOI 10.1183/23120541.01712-2025

    View details for PubMedID 42267381

    View details for PubMedCentralID PMC13244202

  • The San Diego Consensus for Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease. The American journal of gastroenterology Yadlapati, R., Weissbrod, P., Walsh, E., Carroll, T. L., Chan, W. W., Gartner-Schmidt, J., Guadagnoli, L., Jette, M., Myers, J. C., O'Rourke, A., Sweis, R., Wu, J., Barkmeier-Kraemer, J. M., Cates, D., Chen, C. L., Coss-Adame, E., Dion, G., Francis, D., Kaneko, M., Lechien, J. R., Misono, S., Rameau, A., Roman, S., Vertigan, A., Xiao, Y., Zerbib, F., Greytak, M., Pandolfino, J. E., Gyawali, C. P. 2026; 121 (2): 322-336

    Abstract

    The term laryngopharyngeal reflux (LPR) is frequently applied to aerodigestive symptoms despite lack of objective reflux evidence. The aim of this initiative was to develop a modern care paradigm for LPR supported by otolaryngology and gastroenterology disciplines.A 28-member international interdisciplinary working group developed practical statements within the following domains: definition/terminology, initial diagnostic evaluation, reflux monitoring, therapeutic trials, behavioral factors and therapy, and risk stratification. Literature reviews guided statement development and were presented at virtual/in-person meetings. Each statement underwent 2 or more rounds of voting per the RAND Appropriateness Method; statements reaching appropriateness with ≥80% agreement are included as recommendations.The term laryngopharyngeal symptoms (LPS) applies to aerodigestive symptoms with potential to be induced by reflux and include cough, voice change, throat clearing, excess throat phlegm, and throat pain. Laryngopharyngeal reflux disease (LPRD) refers to patients with LPS and objective evidence of reflux. Importantly, the presence of LPS does not equate to LPRD. Laryngoscopy has value in assessing for nonreflux laryngopharyngeal processes, but laryngoscopic findings alone cannot diagnose LPRD. LPS patients should be categorized as with or without concurrent esophageal reflux symptoms. While lifestyle modification and empiric trials of acid suppression ± alginates are appropriate when esophageal reflux symptoms coexist, upper endoscopy and ambulatory reflux monitoring are required for LPRD diagnosis when symptoms persist, when LPS is isolated, or when management needs to be escalated to include invasive antireflux management. The two recommended ambulatory reflux monitoring modalities, 24-hour pH-impedance and 96-hour wireless pH monitoring, are not mutually exclusive with distinct roles for the evaluation of LPS. Laryngeal hyperresponsiveness and hypervigilance commonly contribute to both LPS and LPRD presentations and are responsive to laryngeal recalibration therapy and neuromodulators.The San Diego Consensus represents the formal modern-day interdisciplinary care paradigm to evaluate and manage LPS and LPRD.

    View details for DOI 10.14309/ajg.0000000000003482

    View details for PubMedID 40197644

    View details for PubMedCentralID PMC12353988

  • Exploring Adult Transgender and Gender Diverse Patients' Experiences at a Suburban Academic Medical Center JOURNAL OF PATIENT EXPERIENCE Wharton, M., Jette, M. E., Harris, K. J., Nokoff, N. J., Loeb, D. F., Axelson, Q., Mancuso, M. P., Rothman, M. S., Lee, R. S., Iwamoto, S. J. 2026; 13
  • Internet-Based Behavioral Cough Suppression Therapy for Refractory Chronic Cough: A Randomized Controlled Trial. American journal of speech-language pathology Salois, J. R., Heinle, K. L., Slovarp, L. J., Jetté, M. E., Manchaiah, V., Vlaescu, G., Andersson, G. 2025; 34 (5): 2864-2876

    Abstract

    The purpose of this study was to assess the efficacy of internet-based behavioral cough suppression therapy (IBCST) and explore users' experiences.This study involved a prospective, single-blind, randomized controlled trial comparing the efficacy of a 5-week IBCST and healthy lifestyle education control intervention in patients with refractory chronic cough. Additionally, qualitative interviews were conducted and analyzed using grounded theory methodology.IBCST and the healthy lifestyle control included 5 weeks of asynchronous content delivered via video and text on a study-specific website. IBCST emphasized education and cough suppression.The Leicester Cough Questionnaire (LCQ) and Cough Severity Visual Analog Scale (VAS) were the primary and secondary outcome measures, respectively, and were administered at baseline (T0), 1-week posttreatment (T1), and 1-month posttreatment (T2). Semistructured qualitative interviews were conducted with a subgroup of IBCST participants.Thirty-nine adults with refractory chronic cough enrolled, and 30 (27 women, three men; Mage = 61 years) completed the study (18 IBCST, 12 control). IBCST resulted in clinically significant improvements for 72% of participants in LCQ total score at T1 with a mean change of 3.74 (p = .014, ηp2 = .205) and 76% of participants at T2 with a mean change of 4.1 (p = .033, ηp2 = .163). VAS changes did not reach the minimum clinically meaningful threshold but trended in that direction for the IBCST group at T1 (p = .056, ηp2 = .128). Qualitative analysis revealed IBCST participants liked the convenience and quality of treatment and experienced improvements in symptom control.IBCST was feasible and efficacious and resulted in total LCQ score changes on par with what has been reported for other BCST interventions, paving the way for adaptation to a digital therapeutic.

    View details for DOI 10.1044/2025_AJSLP-25-00124

    View details for PubMedID 40811675

    View details for PubMedCentralID PMC12452824

  • Is Thyrohyoid Space Palpation a Reliable and Useful Clinical Tool Within Diagnostic Protocol for Voice Disorders? Journal of voice : official journal of the Voice Foundation Harris, K. J., Jetté, M. E., Abaza, M., Clary, M. S., Fink, D. S., Litts, J. K. 2025; 39 (5): 1246-1253

    Abstract

    Palpation of the extrinsic laryngeal muscles is a common part of examination performed by otolaryngologists and speech-language pathologists on individuals presenting with voice complaints, thought to aid in diagnosis and treatment planning. While research has identified a significant relationship between thyrohyoid tension and hyperfunctional voice disorders, we are not aware of any studies exploring correlations between thyrohyoid posture during palpation and the full spectrum of voice disorders. This study aims to identify whether patterns in thyrohyoid posture at rest and during phonation can be related to stroboscopic findings and voice disorder diagnoses.A multidisciplinary team of three laryngologists and three speech-language pathologists participated in data collection during 47 new patient visits for voice complaints. Each patient underwent neck palpation and evaluation of thyrohyoid space at rest and during phonation by two independent raters. Clinicians then used stroboscopy to rate glottal closure and supraglottic activity as part of determining primary diagnosis.Strong inter-rater agreement was found for ratings of thyrohyoid space posture both at rest (κ = 0.93) and during phonation (κ = 0.80). Findings revealed no significant correlations between patterns of thyrohyoid posture and laryngoscopic findings or primary diagnoses.Findings suggest that the presented method of laryngeal palpation is a reliable measure for assessing thyrohyoid posture at rest and during phonation. Lack of significant correlation between palpation ratings and other collected measures suggests that this method of palpation is not a useful tool for predicting laryngoscopic findings or voice diagnoses. Laryngeal palpation may still be useful in predicting extrinsic laryngeal muscle tension and guiding treatment planning; however, further research exploring the validity of laryngeal palpation as a measure of extrinsic laryngeal muscle tension is needed, as well as studies that include patient-reported measures and repeated measurements of thyrohyoid posture over time to explore whether thyrohyoid posture is impacted by other factors.

    View details for DOI 10.1016/j.jvoice.2023.03.004

    View details for PubMedID 37076382

  • The Effect of Attentional Manipulation on Cough Reflex Sensitivity in Individuals with Refractory Chronic Cough and Healthy Controls JOURNAL OF CLINICAL MEDICINE Salois, J. R., Slovarp, L. J., Spinti, I., Graham, J., Thorne, J., Glaspey, A., Off, C., Jette, M. 2025; 14 (12)
  • The Effect of Attentional Manipulation on Cough Reflex Sensitivity in Individuals with Refractory Chronic Cough and Healthy Controls. Journal of clinical medicine Salois, J. R., Slovarp, L. J., Spinti, I., Graham, J., Thorne, J., Glaspey, A., Off, C., Jetté, M. 2025; 14 (12)

    Abstract

    Background: Cough reflex sensitivity during cough challenge testing has been found to be modifiable with distraction in groups of healthy individuals. The purpose of this study was to examine this phenomenon in healthy controls and patients with refractory chronic cough (RCC) to advance our understanding of the role attention plays in cough modulation and shed light on avenues for therapeutic advances for RCC. Methods: Thirteen adults with RCC (mean age = 60, 12 women) and twelve healthy controls (mean age = 60, 11 women) participated in this study. The participants completed cough challenge testing with nebulized capsaicin doses tailored to their individual cough reflex sensitivity under distraction and no-distraction conditions. The distraction condition consisted of cough challenge testing while completing a cognitive (visual memory) task on a tablet. Capsaicin doses included the dose that elicited two coughs (C2), and up to three doubling doses above C2. Capsaicin doses were administered in serial order with a placebo dose randomized into the order to control for an anticipation effect during each condition. For each dose administered, the participants were instructed to cough if they needed to. Cough frequency within 15 s and maximal urge-to-cough with each dose were recorded. The order of conditions (distraction or no distraction) was alternated, and all testing was completed within one session. Results: There were no meaningful differences in the dose-response rate parameters for cough frequency or urge-to-cough, respectively, when comparing the results from the RCC group in the condition without distraction to the condition with distraction (p = 0.647, 95% CI = -2.25, 1.15; p = 0.783, 95% CI = -1.94, 0.84), and to the healthy control group without distraction (p = 0.921, 95% CI = -2.11, 2.73, p = 0.887, 95% CI = -1.40, 0.80), and with distraction (p = 0.970, 95% CI = -2.16, 3.36), p = 0.808, 95% CI = -1.49, 0.89). Conclusions: Distraction with the cognitive task chosen in this study did not influence cough reflex sensitivity in either group, which is contrary to studies on healthy volunteers and anecdotal evidence reported by RCC patients. Attentional resources may not have been sufficiently taxed, or too few capsaicin doses were administered to capture an effect as there was high individual variability in cough frequency and urge-to-cough. Additional research is needed to tailor the difficulty of the cognitive task to each participant and incorporate a real-world distraction scenario that may better reveal how attentional manipulation could be harnessed to optimize the effectiveness of behavioral cough suppression therapy for patients with refractory chronic cough.

    View details for DOI 10.3390/jcm14124199

    View details for PubMedID 40565945

    View details for PubMedCentralID PMC12194027

  • Reframing Refractory Chronic Cough: The Role of Interoception LUNG Slovarp, L. J., Reynolds, J. E., Gillespie, A. I., Jette, M. E. 2025; 203 (1): 32

    Abstract

    Refractory chronic cough (RCC) remains a persistent clinical challenge, often resistant to traditional treatments. Emerging evidence now positions RCC as a disorder rooted in hypersensitivity, driven primarily by central neural processes rather than external physiological causes. Central to this understanding is the concept of interoception-the brain's ability to perceive and interpret internal bodily signals. Neuroimaging research has identified abnormalities in brain regions associated with interoception and inhibitory control among RCC patients. Interestingly, RCC shares neurophysiological characteristics with other disorders like overactive bladder and urinary urge incontinence (OAB/UUI), which also involve dysregulated interoceptive and inhibitory mechanisms. Behavioral treatments for OAB/UUI are highly effective and are regarded as the first-line treatment in many consensus guidelines. OAB/UUI behavioral treatments have been shown to induce central neuroplastic changes, further underscoring their efficacy and potential parallel for RCC interventions. Behavioral cough suppression therapy (BCST), an efficacious treatment for RCC, may leverage similar neuroplastic adaptations, enhancing interoceptive processing and inhibitory control. Given the multi-dimensional nature of interoception, which encompasses sensory perception shaped by learning, memory, and emotional context, BCST's engagement of multiple neural pathways offers an alternative therapeutic option compared to single-mechanism pharmacological treatments. Future research should prioritize exploring the mechanistic underpinnings of BCST and other interoception-based therapies for developing more comprehensive and effective treatment options. Such research holds promise for improving patient outcomes, alleviating the significant healthcare burden associated with RCC, and advancing our understanding of central hypersensitivity disorders.

    View details for DOI 10.1007/s00408-025-00786-7

    View details for Web of Science ID 001419137200001

    View details for PubMedID 39937307

    View details for PubMedCentralID PMC11821735

  • Misconceptions on behavioral cough suppression therapy for pediatric nonspecific cough: A response to Weinberger and Buettner's commentary on Fujiki et al. Pediatric pulmonology Slovarp, L., Jette, M., Reynolds, J., Gillespie, A. I., Barkmeier-Kraemer, J., Sandage, M., Smith, J., Haines, J., Vertigan, A., Mazzone, S. 2024; 59 (6): 1525-1527

    View details for DOI 10.1002/ppul.26966

    View details for PubMedID 38483040

  • EXPLORING ADULT PATIENT EXPERIENCES DURING THE FIRST FIVE YEARS OF THE UCHEALTH INTEGRATED TRANSGENDER PROGRAM Wharton, M., Jette, M. E., Harris, K. J., Nokoff, N. J., Loeb, D. F., Axelson, Q., Mancuso, M. P., Rothman, M. S., Lee, R., Iwamoto, S. J. SPRINGER. 2024: S526
  • Normative Values for the Leicester Cough Questionnaire in Healthy Individuals. The Annals of otology, rhinology, and laryngology Reynolds, J. E., Jetté, M. E., Wright, M. L., Sundar, K. M., Gillespie, A. I., Slovarp, L. J. 2023; 132 (6): 705-708

    Abstract

    The primary self-assessment questionnaire used for patients with chronic cough is the Leicester Cough Questionnaire (LCQ). The LCQ is a validated questionnaire that ranges in total score from 3 to 21. While it is known that a higher score on the LCQ reflects a better quality of life, normative data have not been reported for this questionnaire.The purpose of this study was to determine normative LCQ scores on a healthy population without cough.The LCQ was distributed via electronic survey to the authors' universities, professional affiliation email lists, and personal contacts. Participants were included if they were at least 18, nonsmokers, and without abnormal cough, without pulmonary disease, and without neurological disease. Participants answered questions regarding age, gender, and race/ethnicity, and completed the 19 LCQ questions.One hundred forty-three (118 women) LCQ responses were analyzed. Average participant age was 47 years (SD = 13) and 133 (93%) were Caucasian. The mean LCQ Total score was 20.23 (SD = 0.85) with scores ranging from 17.05 to 21.This study determined the following LCQ scores should be considered normal threshold scores: Total score - 17.68, Physical domain - 5.36, Psychological domain - 5.81, and Social domain - 6.06. The findings of this study will assist clinicians in determining severity of cough impact on quality of life using the LCQ. Further research is needed to ensure more complete participant demographic representation.

    View details for DOI 10.1177/00034894221112517

    View details for PubMedID 35833581

  • Variability in P2X receptor composition in human taste nerves: implications for treatment of chronic cough ERJ OPEN RESEARCH High, B., Jette, M. E., Li, M., Ramakrishnan, V. R., Clary, M., Prager, J., Draf, J., Hummel, T., Finger, T. E. 2023; 9 (2)
  • Variability in P2X receptor composition in human taste nerves: implications for treatment of chronic cough. ERJ open research High, B., Jetté, M. E., Li, M., Ramakrishnan, V. R., Clary, M., Prager, J., Draf, J., Hummel, T., Finger, T. E. 2023; 9 (2)

    Abstract

    Antagonists to the P2X purinergic receptors on airway sensory nerves relieve refractory or unexplained chronic cough (RCC/UCC) but can evoke unwanted dysgeusias because the gustatory nerves innervating taste buds express this same family of receptors. However, the subunit composition of the P2X receptors in these systems may differ, with implications for pharmacological intervention of RCC/UCC. In most species, the extrapulmonary airway nerves involved in cough predominantly express P2X3 subunits that form homotrimeric P2X3 receptors. In contrast, most sensory nerves innervating taste buds in mice express both P2X2 and P2X3 subunits, so the majority of receptors in that system are likely P2X2/P2X3 heteromers.Since neural P2X subunit composition can differ across species, we used immunohistochemistry to test whether taste nerves in humans and rhesus macaque monkeys express both P2X2 and P2X3 as in mice.In taste bud samples of fungiform papillae and larynx from humans and monkeys, all taste bud samples exhibited P2X3+ nerve fibres, but the majority lacked substantial P2X2+. Of the 35 human subjects, only four (one laryngeal and three fungiform) showed strong P2X2 immunoreactivity in taste nerves; none of the rhesus monkey samples showed immunoreactivity for P2X2.These findings suggest that for most humans, unlike mice, taste buds are innervated by nerve fibres predominantly expressing only P2X3 homomeric receptors and not P2X2/P2X3 heteromers. Thus, antagonists specific for P2X3 homomeric receptors might not be spared from affecting taste function in RCC/UCC patients.

    View details for DOI 10.1183/23120541.00007-2023

    View details for PubMedID 37057093

    View details for PubMedCentralID PMC10086694

  • Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy. Lung Slovarp, L. J., Jetté, M. E., Gillespie, A. I., Reynolds, J. E., Barkmeier-Kraemer, J. M. 2021; 199 (3): 263-271

    Abstract

    The purpose of this study was to investigate the typical symptoms and medical management characteristics of adult patients with refractory chronic cough (RCC) who are referred to speech-language pathology (SLP) for behavioral cough suppression therapy (BCST) in order to estimate cost-effectiveness and efficiency of current practice patterns for this population.One hundred sixty-four (164) patients with RCC referred for BCST were surveyed. Patients completed an initial survey at BCST onset related to symptom pattern and prior treatment, including the Leicester Cough Questionnaire (LCQ). Every four to six weeks patients completed follow-up surveys to assess their response to BCST.Mean age was 58 years (83.5% women). The majority of patients reported their cough began two or more years prior to BCST. Approximately half (49%) reported seeing four or more physicians (including primary care physicians) and being prescribed four or more medications (57%) prior to BCST. Medications targeting post-nasal drip (72%), reflux (70%), asthma (56%), and allergies (56%) were most commonly prescribed. BCST resulted in a clinically significant improvement in 70.1% of participants. The mean change in LCQ for those who improved with BCST was 6.61. Over half (58%) reported they were quite satisfied to completely satisfied with their treatment response. The average time from enrollment to study completion was 64 days.The results of this study suggest early intervention with BCST may be a cost-effective and efficient option for patients with RCC.

    View details for DOI 10.1007/s00408-021-00442-w

    View details for PubMedID 33821355

    View details for PubMedCentralID PMC8203529

  • Laryngeal Chemoreflex in Health and Disease: A Review. Chemical senses Pathak, S., Slovarp, L., Clary, M. S., Jetté, M. E. 2020; 45 (9): 823-831

    Abstract

    The larynx plays a key role in airway protection via the laryngeal chemoreflex (LCR). This involuntary reflex can be evoked when hazardous substances activate mucosal receptors, which send signals to be processed within the brainstem. Although the LCR is meant to be protective, the reflex can become hyperstimulated, even to benign stimuli, which can result in pathological disorders, such as chronic cough and inducible laryngeal obstruction. In this review, we will outline the mechanism of the LCR and its associated pathological disorders.

    View details for DOI 10.1093/chemse/bjaa069

    View details for PubMedID 33247587

    View details for PubMedCentralID PMC7718607

  • Effect of Unilateral Cordotomy on Perception of Dysphagia. The Annals of otology, rhinology, and laryngology Conklin, M., Clary, M. S., Cuadrado, E. M., Jetté, M. E. 2020; 129 (6): 536-541

    Abstract

    CO2 laser medial transverse cordotomy is a permanent static procedure performed to achieve adequate functional airway in cases of posterior glottic stenosis and bilateral vocal fold paralysis. Although it is the preferred method to manage long-term bilateral vocal fold immobility, it is widely believed that cordotomy has the potential to cause aspiration. The minimal existing data on the effect surgical enlargement of the glottic airway on swallowing function is heterogeneous. Through investigation of dysphagia after cordotomy, we hope to better understand the influence of glottic function and its role in dysphagia. The Eating Assessment Tool (EAT-10), is a validated dysphagia symptom-specific outcome measure. We hypothesized that EAT-10 scores would not change after CO2 laser cordotomy despite causing glottic insufficiency.Retrospective review was performed on sequential patients having undergone unilateral CO2 laser cordotomy with complete pre- and postoperative EAT-10 questionnaire data available for evaluation.Fifteen patients were available for analysis; 10 patients underwent primary unilateral medial transverse cordotomy, 5 patients underwent revision cordotomy, and 20 unique procedures were included in the dataset. The median EAT-10 score during the visit prior to surgery was 3.5, whereas the post-surgery median score was 2. Furthermore, the median difference of 0 was statistically non-significant (P = .91).CO2 laser cordotomy does not contribute to patient-reported dysphagia despite creating glottic incompetence. This suggests vocal fold apposition may play a less significant role in normal swallowing function than widely believed.

    View details for DOI 10.1177/0003489419898711

    View details for PubMedID 31888349

  • Chemical receptors of the arytenoid: A comparison of human and mouse. The Laryngoscope Jetté, M. E., Clary, M. S., Prager, J. D., Finger, T. E. 2020; 130 (2): 423-430

    Abstract

    The larynx is a highly responsive organ exposed to mechanical, thermal, and chemical stimuli. Chemicals elicit responses both in intraepithelial nerve fibers and in specialized chemosensory cells, including scattered solitary cells as well as taste cells organized into taste buds. Activation of both chemosensory cells and taste buds in the larynx elicit cough, swallow, or apnea with exposure to sour or bitter substances, and even by water or sweet-tasting chemicals. In an effort to begin understanding their function, we sought to compare the distribution, density, and types of chemosensory cells and chemoresponsive nerve fibers in laryngeal epithelium of humans and mice.Animal and human laboratory analysis.Using immunohistochemistry, we identified taste cells and polymodal nociceptive nerve fibers in the arytenoid area of the laryngeal epithelium of the following: 1) infants undergoing supraglottoplasty for laryngomalacia, and 2) a cadaveric specimen procured from a 34-year-old donor. We then compared these findings to both preweanling and mature mouse tissue.Arytenoid tissue from both human and mouse contained many taste buds containing type II taste cells-bitter, sweet, or umami sensing-which were innervated by nerve fibers expressing P2X3 type adenosine triphosphate receptors. Type III cells (acid responsive) were also present, but they were fewer in human tissue than in equivalent tissue from mice. In both species, the epithelium was densely innervated by free nerve endings.Our findings suggest that from a standpoint of chemosensation, human and mouse larynges are biologically similar. This suggests that a murine model can be used effectively in laryngeal chemosensory research.NA Laryngoscope, 130:423-430, 2020.

    View details for DOI 10.1002/lary.27931

    View details for PubMedID 30908677

    View details for PubMedCentralID PMC6761039

  • Voice therapy associated with a decrease in the reflux symptoms index in patients with voice complaints LARYNGOSCOPE Schneider, S. L., Clary, M. S., Fink, D., Wang, S. X., Chowdhury, F. N., Yadlapati, R., Jette, M. E., Courey, M. S. 2019; 129 (5): 1169-1173

    Abstract

    Patients with muscle tension dysphonia often demonstrate an elevation in Reflux Symptom Index (RSI) and 10-item Voice Handicap Index (VHI-10) scores, and may be erroneously diagnosed with laryngopharyngeal reflux disease. In this study we assessed the effects of voice therapy on RSI and VHI-10 scores in patients with voice complaints not responsive to antireflux medications.Retrospective cohort study.A study of patients was conducted at a single tertiary-care center over 1 year (January 2012-January 2013). Patients were included if they had dysphonia not responsive to proton pump inhibition, did not have neurologic or neoplastic disease, and participated in at least three voice-therapy sessions in the absence of antireflux therapy. Primary analysis assessed change in RSI scores between the initial and follow-up visits with a laryngologist.A total of 18 patients were included (mean age = 49.9 ± 14.5 years, 89% female, 83% with a primary complaint of dysphonia). From initial to follow-up visit, the median RSI score (18.5 [interquartile range {IQR}, 9.5-22.8] vs. 10.5 [IQR, 4.5-14]; P = .02) and median VHI-10 score (25.5 [IQR, 11.3-30.0] vs. 13.5 [IQR, 9.5-20.8]; P = .03) significantly decreased. A significant inverse correlation was found between the number of voice therapy sessions/month and change in RSI score (r = -0.4; P = .05).In this study of patients with muscle tension dysphonia or vocal hyperfunction not responsive to antireflux therapy, RSI and VHI-10 scores improved following voice therapy. Results suggest that self-reported symptoms typically attributed to laryngopharyngeal reflux disease may actually be secondary to inefficient voice use patterns or anxiety about dysphonia that are responsive to voice therapy.4 Laryngoscope, 129:1169-1173, 2019.

    View details for DOI 10.1002/lary.27583

    View details for Web of Science ID 000467083900041

    View details for PubMedID 30444264

    View details for PubMedCentralID PMC6529330

  • Man vs. Mouse: Comparative Histology of Chemosensory Architecture in the Larynx Jette, M. E., Kinnamon, S. C., Finger, T. E. OXFORD UNIV PRESS. 2018: E39
  • Factors Associated With Infectious Laryngitis: A Retrospective Review of 15 Cases. The Annals of otology, rhinology, and laryngology Thomas, C. M., Jetté, M. E., Clary, M. S. 2017; 126 (5): 388-395

    Abstract

    To identify the culturable microbes associated with infectious laryngitis and outline effective treatment strategies.This is a retrospective chart review of adult patients with persistent dysphonia plus evidence of laryngeal inflammation who underwent biopsy for culture at a tertiary care medical center. Demographic factors, symptoms as reported on validated patient assessment tools, past medical history, social history, culture results, and treatment duration and response were reviewed.Fifteen patients with infectious laryngitis were included in this study. Culture results demonstrated Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Serratia marcescens, and "normal respiratory flora." In most patients, multiple courses of prolonged antibiotics were needed to treat MSSA or MRSA. Infections associated with other microbes resolved with a single course of antibiotics.In this population, infectious laryngitis is defined as colonization with bacteria not found in the previously characterized laryngeal microbiome of benign vocal fold lesions. In suspected cases of infectious laryngitis, culture is recommended, by biopsy if needed. For MSSA- and MRSA-associated laryngitis, an extended course of antibiotics may be necessary for symptom improvement and resolution of laryngeal inflammation. However, the optimal treatment regimen has yet to be defined and will require larger, prospective studies.

    View details for DOI 10.1177/0003489417694911

    View details for PubMedID 28397557

    View details for PubMedCentralID PMC5460979

  • Integrating the microbiota of the respiratory tract with the unified airway model. Respiratory medicine Hanshew, A. S., Jetté, M. E., Rosen, S. P., Thibeault, S. L. 2017; 126: 68-74

    Abstract

    The unified airway model has developed from indications that the upper and lower respiratory tracts share key elements of pathogenesis. These shared traits likely extend to similar niche characteristics that support bacterial communities, and as such, we suspect that similar microbes exist on upper and lower respiratory tract epithelium. Over the past decade and a half there have been significant improvements in microbiological identification and analysis due to the development of new molecular technologies, including next-generation sequencing. In this review, we provide an overview of the modern collection and sequencing methods involved in respiratory microbiota research, and outline the specific microbial communities that have been found to be associated with the healthy and diseased human respiratory tract. Demonstration of a remarkable similarity between the upper and lower respiratory tract in terms of microbiological presence adds further corroboration to the existence of a unified airway.

    View details for DOI 10.1016/j.rmed.2017.03.019

    View details for PubMedID 28427552

    View details for PubMedCentralID PMC5892787

  • Laryngeal T regulatory cells in the setting of smoking and reflux. The Laryngoscope Jetté, M. E., Seroogy, C. M., Thibeault, S. L. 2017; 127 (4): 882-887

    Abstract

    The larynx is a mucosal organ rich in lymphatic tissue that is regularly exposed to a multitude of inhaled, ingested, and refluxed microorganisms and irritants. The first line of mucosal immune defense is the barrier, including resident immune cells. T regulatory (Treg) cells are a specialized subset of CD4+ T cells that suppress or dampen immune responses to prevent damaging immunopathology. As Treg cells have been shown to preferentially accumulate at sites of infection, and Treg responses may contribute to persistence of infection by impairing antibacterial immunity, we sought to quantify these cells in laryngeal tissue exposed to smoking and reflux.Cross-sectional study.Using an epigenetic assay, we quantified Treg and T cells and calculated the ratio of Treg to T cells (i.e., cellular ratio of immune tolerance [ImmunoCRIT]) in disease-free laryngeal biopsies representing four inflammatory states: 1) tobacco-exposed tissue, 2) refluxate and tobacco-exposed tissue, 3) refluxate-exposed tissue, and 4) unexposed tissue.There was epigenetic evidence of Treg cells in all tissues, and we found no differences in Treg cell frequency relative to smoking and reflux in laryngeal tissue collected from 42 non-treatment-seeking participants. There was a decrease in total T cell frequency and an increase in ImmunoCRIT values in smokers regardless of reflux status.In this study, laryngeal tissue from smokers show decreased overall T cells and increased ImmunoCRIT values. Our findings indicate that laryngeal inflammation is not directly mediated by loss of Treg cells in response to smoking and reflux in local tissue and increased ImmunoCRIT values in smokers implicate a role for this environmental exposure in modulating laryngeal immune homeostasis. More studies are indicated to explore Treg cell dysfunction in the pathophysiology of laryngeal disease.NA Laryngoscope, 127:882-887, 2017.

    View details for DOI 10.1002/lary.26223

    View details for PubMedID 27653511

    View details for PubMedCentralID PMC5360507

  • A comparison of sampling methods for examining the laryngeal microbiome. PloS one Hanshew, A. S., Jetté, M. E., Tadayon, S., Thibeault, S. L. 2017; 12 (3): e0174765

    Abstract

    Shifts in healthy human microbial communities have now been linked to disease in numerous body sites. Noninvasive swabbing remains the sampling technique of choice in most locations; however, it is not well known if this method samples the entire community, or only those members that are easily removed from the surface. We sought to compare the communities found via swabbing and biopsied tissue in true vocal folds, a location that is difficult to sample without causing potential damage and impairment to tissue function. A secondary aim of this study was to determine if swab sampling of the false vocal folds could be used as proxy for true vocal folds. True and false vocal fold mucosal samples (swabbed and biopsied) were collected from six pigs and used for 454 pyrosequencing of the V3-V5 region of the 16S rRNA gene. Most of the alpha and beta measures of diversity were found to be significantly similar between swabbed and biopsied tissue samples. Similarly, the communities found in true and false vocal folds did not differ considerably. These results suggest that samples taken via swabs are sufficient to assess the community, and that samples taken from the false vocal folds may be used as proxies for the true vocal folds. Assessment of these techniques opens an avenue to less traumatic means to explore the role microbes play in the development of diseases of the vocal folds, and perhaps the rest of the respiratory tract.

    View details for DOI 10.1371/journal.pone.0174765

    View details for PubMedID 28362810

    View details for PubMedCentralID PMC5375147

  • Case Report: Diagnosis of hypogeusia after oral exposure to commercial cleaning agent and considerations for clinical taste testing. F1000Research Jetté, M., Anderson, C., Ramakrishnan, V. 2017; 6: 373

    Abstract

    Few reports in the literature document acute taste disturbance following exposure to toxic chemicals. We describe the case of a 54-year-old man who presented with primary complaint of tongue numbness and persistent problems with taste 1.5 years following oral exposure to a commercial cleaning agent. A test of olfaction revealed normosmia for age and gender. Lingual tactile two-point discrimination testing showed reduced somatosensation. Taste threshold testing using a 3-drop method demonstrated severe hypogeusia, though the patient was able to discriminate tastants at lower concentrations with a whole mouth swish and spit test. We conclude that clinical evaluation of dysgeusia can be performed using a number of previously published testing methods, however, determining causative factors may be confounded by duration since exposure, lack of knowledge of baseline taste function, and medications. Although many testing options exist, basic taste testing can be performed with minimal expertise or specialized equipment, depending on the patient history and goals of evaluation.

    View details for DOI 10.12688/f1000research.11241.2

    View details for PubMedID 28713552

    View details for PubMedCentralID PMC5490477

  • The human laryngeal microbiome: effects of cigarette smoke and reflux. Scientific reports Jetté, M. E., Dill-McFarland, K. A., Hanshew, A. S., Suen, G., Thibeault, S. L. 2016; 6: 35882

    Abstract

    Prolonged diffuse laryngeal inflammation from smoking and/or reflux is commonly diagnosed as chronic laryngitis and treated empirically with expensive drugs that have not proven effective. Shifts in microbiota have been associated with many inflammatory diseases, though little is known about how resident microbes may contribute to chronic laryngitis. We sought to characterize the core microbiota of disease-free human laryngeal tissue and to investigate shifts in microbial community membership associated with exposure to cigarette smoke and reflux. Using 454 pyrosequencing of the 16S rRNA gene, we compared bacterial communities of laryngeal tissue biopsies collected from 97 non-treatment-seeking volunteers based on reflux and smoking status. The core community was characterized by a highly abundant OTU within the family Comamonadaceae found in all laryngeal tissues. Smokers demonstrated less microbial diversity than nonsmokers, with differences in relative abundances of OTUs classified as Streptococcus, unclassified Comamonadaceae, Cloacibacterium, and Helicobacter. Reflux status did not affect microbial diversity nor community structure nor composition. Comparison of healthy laryngeal microbial communities to benign vocal fold disease samples revealed greater abundance of Streptococcus in benign vocal fold disease suggesting that mucosal dominance by Streptococcus may be a factor in disease etiology.

    View details for DOI 10.1038/srep35882

    View details for PubMedID 27775059

    View details for PubMedCentralID PMC5075886

  • Taste Buds and Solitary Chemosensory Cells in the Infant Human Larynx Jette, M. E., Clary, M. S., Prager, J. D., Kinnamon, S. C., Finger, T. E. OXFORD UNIV PRESS. 2016: E105-E106
  • Quantification of Porcine Vocal Fold Geometry. Journal of voice : official journal of the Voice Foundation Stevens, K. A., Thomson, S. L., Jetté, M. E., Thibeault, S. L. 2016; 30 (4): 416-26

    Abstract

    The aim of this study was to quantify porcine vocal fold medial surface geometry and three-dimensional geometric distortion induced by freezing the larynx, especially in the region of the vocal folds.The medial surface geometries of five excised porcine larynges were quantified and reported.Five porcine larynges were imaged in a micro-CT scanner, frozen, and rescanned. Segmentations and three-dimensional reconstructions were used to quantify and characterize geometric features. Comparisons were made with geometry data previously obtained using canine and human vocal folds as well as geometries of selected synthetic vocal fold models.Freezing induced an overall expansion of approximately 5% in the transverse plane and comparable levels of nonuniform distortion in sagittal and coronal planes. The medial surface of the porcine vocal folds was found to compare reasonably well with other geometries, although the compared geometries exhibited a notable discrepancy with one set of published human female vocal fold geometry.Porcine vocal folds are qualitatively geometrically similar to data available for canine and human vocal folds, as well as commonly used models. Freezing of tissue in the larynx causes distortion of around 5%. The data can provide direction in estimating uncertainty due to bulk distortion of tissue caused by freezing, as well as quantitative geometric data that can be directly used in developing vocal fold models.

    View details for DOI 10.1016/j.jvoice.2015.06.009

    View details for PubMedID 26292797

    View details for PubMedCentralID PMC4757522

  • Vocal fold myofibroblast profile of scarring. The Laryngoscope Branco, A., Bartley, S. M., King, S. N., Jetté, M. E., Thibeault, S. L. 2016; 126 (3): E110-7

    Abstract

    Vocal fold fibroblasts (VFF) are responsible for extracellular matrix synthesis supporting lamina propria in normal and diseased conditions. When tissue is injured, VFF become activated and differentiate into myofibroblasts to facilitate wound healing response. We investigated if vocal fold myofibroblasts can be utilized as surrogate cells for scarred VFF.In vitro.Normal VFF cell lines from a 21-year-old male (N21), 59-year-old female (N59), and a scar VFF cell line from a 56-year-old female (S56) were used in this study. 10 ng/mL of transforming growth factor (TGFβ1) was applied for 5 days to normal VFF. Myofibroblast differentiation was determined with immunocytochemistry and western blot, measuring alpha smooth muscle actin (α-SMA). Cell growth, proliferation, contractile properties, and gene expression profiles were evaluated.N21, N59, and S56 VFF presented elongated configuration. N21+ and N21- VFF demonstrated significantly greater proliferation compared to N59+, N59-, and S56 VFF at 6 days. α-SMA was expressed in all cells. Fibronectin, alpha smooth actin, connective tissue growth factor, and metallopeptidase inhibitor were the highest genes expression in VFF treated with transforming growth factor β1 (TGFβ1). At 24 hours, S56 VFF showed lower contraction compared to N21+ and N59+ VFF, but at 60 hours S56 VFF had lower collagen contraction compared to all cell groups. Highest collagen contraction matrices were measured with VFF treated with TGFβ1 at 24 hours and N59- VFF at 60 hours.VFF treated with TGFβ1 (myofibroblasts) appear to have similar phenotypic characteristics but different genotypic behavior compared to scar VFF.N/A. Laryngoscope, 126:E110-E117, 2016.

    View details for DOI 10.1002/lary.25581

    View details for PubMedID 26344050

    View details for PubMedCentralID PMC4755903

  • Toward an Understanding of the Pathophysiology of Chronic Laryngitis. Perspectives of the ASHA special interest groups Jetté, M. 2016; 1 (3): 14-25

    Abstract

    Chronic laryngitis, characterized by inflammation of the laryngeal tissues, is the most commonly diagnosed organic voice disorder, yet treatments targeting suspected etiologic factors have demonstrated limited efficacy. A major barrier to the development of improved medical therapies for chronic laryngitis is a fundamental gap in knowledge related to the pathophysiology of laryngeal inflammation. This article provides a review of the literature specific to laryngeal immunity in health and disease.

    View details for DOI 10.1044/persp1.sig3.14

    View details for PubMedID 32864454

    View details for PubMedCentralID PMC7451247

  • Characterization and comparison of bacterial communities in benign vocal fold lesions MICROBIOME Hanshew, A. S., Jette, M. E., Thibeault, S. L. 2014; 2
  • Correlation between Reflux and multichannel intraluminal impedance pH monitoring in untreated volunteers. The Laryngoscope Jetté, M. E., Gaumnitz, E. A., Birchall, M. A., Welham, N. V., Thibeault, S. L. 2014; 124 (10): 2345-51

    Abstract

    Although probable causative agents have been identified (e.g., refluxate components, tobacco smoke), the definitive mechanism for inflammation-related laryngeal mucosal damage remains elusive. Multichannel intraluminal impedance combined with pH monitoring (MII/pH) has emerged as a sensitive tool for diagnosis and characterization of gastroesophageal reflux disease with laryngopharyngeal manifestations. To determine the relationship between laryngeal signs and MII/pH, we examined correlations between Reflux Finding Score (RFS) ratings of videostroboscopic laryngeal examinations and findings from MII/pH.Correlational study.Healthy, untreated volunteers (n = 142) underwent reflux diagnosis using data acquired from MII/pH testing. Eight trained clinicians performed RFS ratings of corresponding laryngeal examinations. Averaged RFS ratings were compared to MII/pH data using Pearson correlation coefficients. The relationship between RFS and MII/pH findings and demographic/clinical information (age, sex, smoking status, reflux) was assessed using general linear modeling. Rater reliability was evaluated.Posterior commissure hypertrophy was negatively correlated with minutes of nonacid refluxate (R = -0.21, P = .0115). General linear modeling revealed that 28% to 40% of the variance in ratings of ventricular obliteration, erythema/hyperemia, vocal fold edema, diffuse laryngeal edema, posterior commissure hypertrophy, and granulation/granuloma could be explained by main and interaction effects of age, sex, smoking status, and reflux. Intra- and inter-rater reliability for RFS were poor-fair.These results support the theory that the RFS is not specific for reflux in healthy, untreated volunteers, suggesting there may be alternate explanations for inflammatory clinical signs commonly ascribed to reflux in this population.

    View details for DOI 10.1002/lary.24737

    View details for PubMedID 24782404

    View details for PubMedCentralID PMC4203695

  • Characterization of human vocal fold fibroblasts derived from chronic scar. The Laryngoscope Jetté, M. E., Hayer, S. D., Thibeault, S. L. 2013; 123 (3): 738-45

    Abstract

    In vitro modeling of cell-matrix interactions that occur during human vocal fold scarring is uncommon, as primary human vocal fold scar fibroblast cell lines are difficult to acquire. The purpose of this study was to characterize morphologic features, growth kinetics, contractile properties, α-smooth muscle actin (α-SMA) protein expression and gene expression profile of human vocal fold fibroblasts derived from scar (sVFF) relative to normal vocal fold fibroblasts (nVFF).In vitro.We successfully cultured human vocal fold fibroblasts from tissue explants of scarred vocal folds from a 56-year-old female and compared these to normal fibroblasts from a 59-year-old female. Growth and proliferation were assessed by daily cell counts, and morphology was compared at 60% confluence for 5 days. Gel contraction assays were evaluated after seeding cells within a collagen matrix. α-SMA was measured using western blotting and immunocytochemistry (ICC). Quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) was used to assess differential extracellular matrix gene expression between the two cell types.sVFF were morphologically indistinguishable from nVFF. sVFF maintained significantly lower proliferation rates relative to nVFF on days 3 to 6 (day 3: P = .0138; days 4, 5, and 6: P < .0001). There were no significant differences in contractile properties between the two cell types at any time point (0 hours: P = .70, 24 hours: P = .79, 48 hours: P = .58). ICC and western blot analyses revealed increased expression of α-SMA in sVFF as compared with nVFF at passages 4 and 5, but not at passage 6 (passage 4: P = .006, passage 5: P = .0015, passage 6: P = .8860). Analysis of 84 extracellular matrix genes using qRT-PCR revealed differential expression of 15 genes (P < .01).nVFF and sVFF displayed differences in proliferation rates, α-SMA expression, and gene expression, whereas no differences were observed in contractile properties or morphology. Further investigation with a larger sample size is necessary to confirm these findings.

    View details for DOI 10.1002/lary.23681

    View details for PubMedID 23444190

    View details for PubMedCentralID PMC3584344

  • Vocal fold fibroblasts immunoregulate activated macrophage phenotype. Cytokine King, S. N., Chen, F., Jetté, M. E., Thibeault, S. L. 2013; 61 (1): 228-36

    Abstract

    Recent evidence suggests that fibroblasts play a critical role in regulating inflammation during wound healing because they express several inflammatory mediators in response to bacteria. The objective of this study was to analyze the effects of lipopolysaccharide (LPS) on the immunomodulatory properties of vocal fold fibroblasts (VFFs) derived from polyps, scar and normal tissue co-cultured with macrophages, to provide insight into their interactions during the inflammatory process. Fibroblasts were co-cultured with CD14+ monocytes and after 7 days, wells were treated with LPS for 24 and 72 h. Culture supernatants were collected and concentrations of TNF-α, IL-6, IL-8, IL-10, IL-12, IL-1β and MCP-1 were quantified by ELISA. Normal VFF and CD14+ monocultures were used as controls. Twenty-four hours after LPS activation, macrophages co-cultured with polyp VFF had significantly increased expression of TNF-α, IL-1β, IL-12 and IL-10 compared to controls (p<0.0001). In contrast, macrophages co-cultured with scar VFF had significantly lower expression of TNF-α, IL-1β and IL-12 with significantly higher IL-10 compared to control (p<0.0001). After 72 h, macrophages co-cultured with polyp VFF increased expression of TNF-α, IL-1β, IL-10, IL-6, IL-8, MCP-1 and TGF-β (p<0.01) and macrophages co-cultured with scar VFF significantly decreased their expression of IL-1β and IL-12 compared to control (p<0.0001). Scar VFF at both time points produced significantly lower levels of IL-8, MCP-1, IL-6 and TGF-β compared to controls (p<0.05). Based on our findings, VFF and macrophages secrete several inflammatory mediators that modify their diverse functions. Polyp and scar VFF may play a role in regulating abnormal inflammatory responses, which could result in excessive ECM deposition that disrupts the function of the vocal folds.

    View details for DOI 10.1016/j.cyto.2012.09.023

    View details for PubMedID 23123198

    View details for PubMedCentralID PMC3505241

  • Fundamental approaches in molecular biology for communication sciences and disorders. Journal of speech, language, and hearing research : JSLHR Bartlett, R. S., Jetté, M. E., King, S. N., Schaser, A., Thibeault, S. L. 2012; 55 (4): 1220-31

    Abstract

    This contemporary tutorial will introduce general principles of molecular biology, common deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and protein assays and their relevance in the field of communication sciences and disorders.Over the past 2 decades, knowledge of the molecular pathophysiology of human disease has increased at a remarkable pace. Most of this progress can be attributed to concomitant advances in basic molecular biology and, specifically, the development of an ever-expanding armamentarium of technologies for analysis of DNA, RNA, and protein structure and function. Details of these methodologies, their limitations, and examples from the communication sciences and disorders literature are presented. Results/Conclusions The use of molecular biology techniques in the fields of speech, language, and hearing sciences is increasing, facilitating the need for an understanding of molecular biology fundamentals and common experimental assays.

    View details for DOI 10.1044/1092-4388(2011/11-0152)

    View details for PubMedID 22232415

    View details for PubMedCentralID PMC3418393

  • Characteristics of phonatory function in singers and nonsingers with vocal fold nodules. Journal of voice : official journal of the Voice Foundation Stepp, C. E., Heaton, J. T., Stadelman-Cohen, T. K., Braden, M. N., Jetté, M. E., Hillman, R. E. 2011; 25 (6): 714-24

    Abstract

    The goals of this study were to determine if there were significant differences between singers and nonsingers in the morphology of vocal nodules and the associated impact on vocal function.Participants were 10 professionally trained singers with nodules, eight nonsingers with nodules, and 10 individuals with healthy normal voice (controls). Surface electromyography (sEMG) from three anterior neck locations and acoustic rise times for vowels /a/ and /i/ were measured in all the participants. In individuals with nodules, dB SPL/cm H(2)O, glottal airflow, and nodule location and size were also measured.There were no significant differences between singers and nonsingers with nodules in terms of airflow, dB SPL/cm H(2)O, nodule size, or nodule location. In nonsingers with nodules, airflow and nodule size were significantly correlated, but were not significantly correlated in singers. Vowel rise times and sEMG during vocal tasks did not differentiate among nodule and control groups. Sternocleidomastoid sEMG during initiation of the vowel /a/ was statistically significantly stronger in nonsingers with nodules relative to singers with nodules and controls.Nodule morphology did not differ between singers and nonsingers, although some behavioral aspects of phonation differed between the groups.

    View details for DOI 10.1016/j.jvoice.2010.06.003

    View details for PubMedID 21216129

    View details for PubMedCentralID PMC3117117

  • Comparison of neck tension palpation rating systems with surface electromyographic and acoustic measures in vocal hyperfunction. Journal of voice : official journal of the Voice Foundation Stepp, C. E., Heaton, J. T., Braden, M. N., Jetté, M. E., Stadelman-Cohen, T. K., Hillman, R. E. 2011; 25 (1): 67-75

    Abstract

    The purpose of this study was to evaluate current neck tension palpation rating systems to determine interrater reliability and possible correlation with necksurface electromyography (sEMG, collected from three electrode recording locations) and to measure the third formant for /a/ during various vocal behaviors. This prospective study examined the neck muscle tension of 16 participants before and after a single session of voice therapy. Interrater reliability and relationships between palpation ratings and objective measures of sEMG (anterior neck) and the third formant for /a/ were assessed using Pearson's correlations (r). Interrater reliability was relatively low as measured by Pearson's correlations, although Wilcoxon signed-rank test results were similar as those in a previous study. Correlations between palpation ratings and sEMG and between ratings of laryngeal height and the third formant for /a/ were generally low. Correlations increased between anterior neck sEMG and ratings of suprahyoid muscle tension when examined in a reduced set of individuals with higher interrater reliability. Palpation rating scales do not reliably capture changes that may occur in neck muscle tension of typical voice therapy patients over one session. Consequently, little can be concluded from correlations between sEMG and palpation ratings.

    View details for DOI 10.1016/j.jvoice.2009.08.001

    View details for PubMedID 20347260

    View details for PubMedCentralID PMC2913165

  • Neck surface electromyography as a measure of vocal hyperfunction before and after injection laryngoplasty. The Annals of otology, rhinology, and laryngology Stepp, C. E., Heaton, J. T., Jetté, M. E., Burns, J. A., Hillman, R. E. 2010; 119 (9): 594-601

    Abstract

    The goal of this preliminary study was to determine whether neck surface electromyography (sEMG) is sensitive to possible changes in vocal hyperfunction associated with injection laryngoplasty, particularly with respect to alterations in the degree of vocal hyperfunction.Thirteen individuals undergoing office-based injection laryngoplasty for glottal phonatory insufficiency were prospectively studied with a battery of acoustic, aerodynamic, endoscopic, and anterior neck sEMG assessments before the procedure and approximately 1 week afterward.Anterior neck sEMG values were not significantly reduced (p < 0.05) after the procedure; however, perceptual ratings of strain and false vocal fold compression were both significantly reduced, reflecting a decrease in vocal hyperfunction.The results do not support the use of anterior neck sEMG measures to assess vocal hyperfunction, and place into question the use of some other measures (estimates of anterior-posterior supraglottic compression, quantitative measures of anterior-posterior and false vocal fold supraglottic compression, and acoustic vowel rise times) that have been considered reflective of vocal hyperfunction.

    View details for DOI 10.1177/000348941011900905

    View details for PubMedID 21033026

    View details for PubMedCentralID PMC3392645

  • Quantifying dysphonia severity using a spectral/cepstral-based acoustic index: Comparisons with auditory-perceptual judgements from the CAPE-V. Clinical linguistics & phonetics Awan, S. N., Roy, N., Jetté, M. E., Meltzner, G. S., Hillman, R. E. 2010; 24 (9): 742-58

    Abstract

    This study investigated the relationship between acoustic spectral/cepstral measures and listener severity ratings in normal and disordered voice samples. CAPE-V sentence samples and the vowel /a/were elicited from eight normal speakers and 24 patients with varying degrees of dysphonia severity. Samples were analysed for measures of the cepstral peak prominence (CPP), the ratio of low-to-high spectral energy, and their respective standard deviations. Perceptual ratings of overall severity were also obtained for all samples. Results showed that all acoustic variables combined in a four-factor model which correlated with perceived severity with R = 0.81 (R(2) = 0.65). For the vowel /a/, a five-factor model incorporating all acoustic variables and gender correlated with perceived severity with R = 0.96 (R(2) = 0.91). Results indicate that a strong relationship between perceptual and acoustic estimates of dysphonia severity can be achieved in both continuous speech and vowel contexts using a model incorporating spectral/cepstral measures.

    View details for DOI 10.3109/02699206.2010.492446

    View details for PubMedID 20687828